Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |